1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Insulinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Chen, H; Chen, X; Jacobson, O; Kiesewetter, DO; Lang, L; Ma, Y; Niu, G; Tong, X; Wu, H; Yang, X; Yung, BC | 1 |
| Chen, X; Deng, H; Jacobson, O; Kang, F; Kiesewetter, DO; Lang, L; Ma, Y; Niu, G; Tang, L; Wang, J; Wang, Z; Yang, W; Zhang, M | 1 |
| Chen, X; Kiesewetter, DO; Li, F; Luo, Y; Pan, Q; Wu, W; Yu, M; Zhang, T; Zhao, Y; Zhu, Z | 1 |
| Chen, F; Liu, P; Luo, S; Pan, D; Sun, X; Wang, L; Xu, Q; Xu, Y; Yang, M; Yang, R; Zhu, C | 1 |
| Chen, X; Kiesewetter, DO; Li, F; Li, N; Luo, Y | 1 |
| Chen, X; Kiesewetter, DO; Li, F; Luo, Y; Pan, Q; Wu, W; Xue, H; Yao, S; Yu, M; Zhao, Y; Zhu, Z | 1 |
1 trial(s) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Insulinoma
| Article | Year |
|---|---|
Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
Topics: Adolescent; Adult; Aged; Child; Cohort Studies; Exenatide; Female; Gallium Radioisotopes; Glucagon-Like Peptide-1 Receptor; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Peptides; Positron Emission Tomography Computed Tomography; Prospective Studies; Venoms; Young Adult | 2016 |
5 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Insulinoma
| Article | Year |
|---|---|
Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.
Topics: Animals; Antineoplastic Agents; Bevacizumab; Blood Volume; Capillary Permeability; Carcinoma; Disease Models, Animal; Evans Blue; Fluorine Radioisotopes; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Insulinoma; Positron-Emission Tomography; Rats | 2017 |
Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.
Topics: Animals; Exenatide; Female; Gallium Radioisotopes; Glucagon-Like Peptide-1 Receptor; HEK293 Cells; Heterocyclic Compounds, 1-Ring; Humans; Insulinoma; Mice; Positron-Emission Tomography; Theranostic Nanomedicine | 2019 |
68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake.
Topics: Exenatide; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Insulinoma; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venoms | 2015 |
Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.
Topics: Animals; Cell Line, Tumor; Cysteine; Drug Stability; Exenatide; Female; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Insulinoma; Maleimides; Mice; Mice, Nude; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Rats; Venoms | 2015 |
68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma.
Topics: Carcinoma; Coordination Complexes; Esophageal Neoplasms; Exenatide; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Insulinoma; Liver Neoplasms; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venoms | 2016 |